Ocutech, Inc. Announces National Launch of Revolutionary Sightscope FLIP Device

Share Article

International Low Vision Product Developer Introduces First-of-its-kind Bioptic Telescope.

Ocutech, Inc., a worldwide leader in developing high quality eyeglass telescopes for the visually impaired, has officially announced the launch of their new and innovative Sightscope FLIP device. With the Sightscope FLIP, Ocutech is providing the visually impaired with the first-ever binocular bioptic telescope device that is fully adjustable, maximizes the field of view, can be adapted for reading, is stylish and flips out of the way when not in use.

According to Dr. Henry Greene, Ocutech, Inc.’s Co-Founder and President, the Sightscope FLIP was developed to meet consumer and prescriber demand for a product that offered a better balance between enhanced vision, affordability, good looks and ease of use.

“The Sightscope FLIP is our newest advance since Dr. Russ Pekar invented Ocutech’s first VES low vision device nearly thirty years ago,” said Dr. Greene. “After decades of innovation, we are proud to announce that our Sightscope FLIP will enable low vision specialists to offer their patients a high quality, attractive and affordable bioptic telescope. We are excited to provide visually impaired people with a device that builds confidence because it makes them look good and allows them to see and do things they might never have thought possible.”

The Sightscope FLIP’s novel features sparked rave reviews from both prescriber and patient early evaluators. For prescribers, the new product makes life easy because of its convenient prescribing options. The device can be prescribed for one or two eyes, function on standard and custom eyeglass frames, and be prescribed in different positions depending upon how the device will be used.

Dr. Kendall Krug, a Sightscope FLIP early evaluator and American Board of Optometry member, maintains a private optometry practice in Hays, KS. He echoes Dr. Greene’s perspective and says he already has many satisfied patients using the Sightscope FLIP.

“I have had nothing but positive experiences so far,” said Dr. Krug. “The Sightscope FLIP is unlike any other bioptic telescope on the market because it is so simple to prescribe, easy to use, and comes at a price patients can afford. Several of my patients are already using their Sightscope FLIP as their primary low vision device and they couldn’t be happier.”

For low vision patients, however, the Sightscope FLIP’s appeal is all about functionality and appearance. For example, Tim Goetz, a user experienced with Ocutech’s full range of products, loves his new Sightscope FLIP, especially while traveling. Seeing the traffic, avoiding obstacles on the road, and positioning the car in intersections and lane changes has become second nature– something that is critically important for the 75,000 miles he drives for his job each year.

“There is nothing else on the market like the Sightscope FLIP,” said Goetz. “Not only does the device enable me to see better at night as well as during the day, it also provided me with a wide enough field of vision and strong enough depth perception to retain my Navy certification. The Sightscope FLIP is perfect for me because I can flip them in place to drive the thousands of miles I log each month, and easily flip them out of the way when I sit down to meet with customers.”

“For the first time in my life, I have a silver, sleek and effective low vision device that doesn’t generate negative responses for the way that it looks. That’s the best of both worlds for me and anyone else who is visually impaired.”

Please visit Ocutech’s website (http://www.ocutech.com) or call the company’s corporate headquarters toll-free at (800) 326-6460 for more information on the Sightscope FLIP and Ocutech’s full line of bioptic telescopes and for a referral to an Ocutech specialist.

About Ocutech, Inc.

Ocutech Inc., founded in 1984 by Russ Pekar, Ph.D. and optometrist, Dr. Henry Greene, has become a worldwide leader in creating innovative hi-quality telescopic eyeglasses for the visually impaired. Over the years, Ocutech has received grant support from the National Eye Institute (NEI) and the Ontario (Canada) Ministry of Health totaling over $1.5 million. Their bioptic systems were preferred 3 to 1 in independent NIH-funded clinical trials. Ocutech VES-bioptic telescopes are now used by many thousands of visually impaired individuals throughout the world.

Ocutech’s original telescope, called the Vision Enhancing System (VES), was invented by Dr. Pekar, who is himself visually impaired. Dr. Pekar personally understood the unique needs and challenges faced daily by the visually impaired as well as the limitations of conventional telescopic low vision aids. Since then, Ocutech has continued to create a diverse range of telescopic low vision aids, including the first-ever autofocusing device, that enable individuals with visual impairments to enhance their vision for school, work and social activities and hence to maximize their quality of life.

Ocutech low vision aids are helpful for individuals with vision loss from macular degeneration, Stargardt’s Disease, albinism, nystagmus and a range of other acquired and inherited vision disorders that affect the macula. Ocutech’s products are known for being effective, easy to prescribe and use, and attractive and comfortable to wear.

Today, Ocutech is led by its co-founder, Dr. Greene, a practicing optometrist and former UNC-Chapel Hill Clinical Professor of Ophthalmology. He remains dedicated to creating low vision products that fit the modern day needs of the visually impaired. In 2013, Ocutech and Dr. Greene unveiled the company’s newest product, the Sightscope FLIP, the first ever binocular bioptic telescope device that is fully adjustable, maximizes the field of view, can be adapted for reading, is stylish, and flips out of the way when not in use.

For more information about Ocutech, please visit http://www.ocutech.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Graham Chapman
Email >
Visit website